“…An animal model that reproduces the processes taking place in the development of human atherosclerosis has been crucial to obtaining these conclusions, and this has been provided by the apoE-deficient mouse. Using this model, it has been proved that EVOO possesses beneficial antiatherogenic effects, and its enrichment with polyphenols (Rosenblat et al, 2008) and with long chain n-3 PUFAs (Eilertsen et al, 2011) further improves these effects, leading to the attenuation of atherosclerosis development. Feeding these mice with various olive oils rich in different minor components or with these components in isolation has made it possible to assess the contribution of those molecules to the beneficial effect of this food, these effects have been review by Guillen et al, 2009 and include the following: 1) increase of small, dense HDL enriched with apo A-IV tightly bound to paraoxonase; these apolipoprotein A-IV-enriched particles were very effective in inactivating the peroxides present in the low-density lipoproteins (LDL) which are thought to initiate atherosclerosis; 2) minor components decrease plasma triglycerides and LDL-colesterol and very low density lipoprotein cholesterol (VLDL-colesterol), as well as 3) parameters of oxidative stress, such as isoprostane (8-iso-prostaglandin F2a); 4) EVOO acts against oxidative stress, which occurs primarily through a direct antioxidant effect as well as through an indirect mechanism that involves greater expression and activity of certain enzymes with antioxidant activities such as catalase and glutathione peroxidase-1 (Oliveras- Lopez et al, 2008).…”